Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes

医学 自身免疫性脑炎 美罗华 免疫疗法 改良兰金量表 脑炎 内科学 免疫学 抗体 免疫系统 病毒 缺血 缺血性中风
作者
Woojin Lee,Han-Sang Lee,Do-Yong Kim,Hye-Sung Lee,Jangsup Moon,Kyung‐Il Park,Sang Kun Lee,Kon Chu
出处
期刊:Brain [Oxford University Press]
卷期号:145 (10): 3509-3521 被引量:18
标识
DOI:10.1093/brain/awac166
摘要

Abstract Seronegative autoimmune encephalitis is autoimmune encephalitis without any identifiable pathogenic antibody. Although it is a major subtype of autoimmune encephalitis, many unmet clinical needs exist in terms of clinical characteristics, treatments and prognosis. In this institutional cohort study, patients diagnosed with seronegative autoimmune encephalitis with available 2-year outcomes were analysed for the disease course, 2-year outcome prediction system, effect of immunotherapy, necessity of further immunotherapy at 6 or 12 months and pattern of brain atrophy. Seronegative autoimmune encephalitis was subcategorized into antibody-negative probable autoimmune encephalitis, autoimmune limbic encephalitis and acute disseminated encephalomyelitis. Poor 2-year outcome was defined by modified Rankin scale scores 3–6, and the 2-year serial data of Clinical Assessment Scales in Autoimmune Encephalitis score was used for longitudinal data analyses. A total of 147 patients were included. The frequency of achieving a good 2-year outcome (modified Rankin scale 0–2) was 56.5%. The antibody-negative probable autoimmune encephalitis subtype exhibited the poorest outcomes, although the baseline severity was similar among the subtypes. The RAPID score, consisting of five early usable clinical factors, refractory status epilepticus, age of onset ≥60 years, probable autoimmune encephalitis (antibody-negative probable autoimmune encephalitis subtype), infratentorial involvement and delay of immunotherapy ≥1 month, was associated with poorer 2-year outcomes. Any immunotherapy was associated with clinical improvement in the patients with low risk for poor 2-year outcomes (RAPID scores 0–1), and the combination immunotherapy of steroid, immunoglobulin, rituximab and tocilizumab was associated with better outcomes in the patients with high risk for poor 2-year outcomes (RAPID scores 2–5). In patients with persistent disease at 6 months, continuing immunotherapy was associated with more improvement, while the effect of continuing immunotherapy for more than 12 months was unclear. In the longitudinal analysis of MRI, the development of cerebellar atrophy indicated poor outcomes, while the absence of diffuse cerebral atrophy or medial temporal atrophy indicated the possibility of a good outcome. This study provides information about the clinical characteristics and courses, the effect of immunotherapy and its duration, and prognostic factors in seronegative autoimmune encephalitis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI5应助PanCiro采纳,获得30
刚刚
1秒前
包子完成签到,获得积分20
1秒前
夜幕云端完成签到,获得积分10
1秒前
wanci应助bofu采纳,获得10
2秒前
爆米花应助调皮的沛萍采纳,获得10
3秒前
3秒前
Chris发布了新的文献求助10
7秒前
8秒前
杨大仙儿发布了新的文献求助10
8秒前
wuxiaoshu完成签到 ,获得积分20
10秒前
等待纸鹤发布了新的文献求助10
10秒前
七七发布了新的文献求助10
11秒前
Akim应助bofu采纳,获得30
11秒前
necos发布了新的文献求助10
12秒前
16秒前
16秒前
17秒前
18秒前
18秒前
CodeCraft应助阮绝悟采纳,获得10
19秒前
归海含烟完成签到,获得积分10
19秒前
吴陈发布了新的文献求助10
19秒前
隐形曼青应助zhentg采纳,获得10
20秒前
20秒前
wuyan204完成签到,获得积分10
21秒前
21秒前
lulululu发布了新的文献求助10
21秒前
Mer_Mer完成签到,获得积分10
21秒前
csj发布了新的文献求助10
21秒前
bofu发布了新的文献求助10
21秒前
研友_VZG7GZ应助七七采纳,获得30
21秒前
22秒前
23秒前
23秒前
23秒前
wuyan204发布了新的文献求助10
24秒前
NexusExplorer应助大黄柿子采纳,获得10
24秒前
24秒前
25秒前
高分求助中
Continuum Thermodynamics and Material Modelling 4000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
El viaje de una vida: Memorias de María Lecea 800
Theory of Block Polymer Self-Assembly 750
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3514588
求助须知:如何正确求助?哪些是违规求助? 3096951
关于积分的说明 9233306
捐赠科研通 2791978
什么是DOI,文献DOI怎么找? 1532173
邀请新用户注册赠送积分活动 711816
科研通“疑难数据库(出版商)”最低求助积分说明 707031